Skip to main content
International Journal of Ophthalmology logoLink to International Journal of Ophthalmology
. 2016 Jan 18;9(1):159–162. doi: 10.18240/ijo.2016.01.26

Ophthalmologic manifestations of celiac disease

Thiago Gonçalves dos Santos Martins 1, Ana Luiza Fontes de Azevedo Costa 2, Maria Kiyoko Oyamada 2, Paulo Schor 1, Aytan Miranda Sipahi 3
PMCID: PMC4768497  PMID: 26949627

Abstract

Celiac disease is an autoimmune disorder that affects the small intestine of genetically predisposed individuals. Ophthalmic manifestations are within the extra-intestinal manifestations, and can be divided into those of autoimmune disorders or those due to absorptive disabilities. This article reviewed the ophthalmologic manifestation of celiac disease. Ophthalmic symptoms are rare, but should be investigated in patients with celiac disease and taken into consideration as the first systemic manifestation.

Keywords: ophthalmology, celiac disease, review

INTRODUCTION

Celiac disease is an autoimmune disease that affects the small intestine of genetically predisposed individuals. This disease can be asymptomatic and can have gastrointestinal or extra-intestinal symptoms. The classic symptoms are part of a malabsorptive syndrome with diarrhea and weight loss. Approximately 50% of the patients present with atypical or extra-intestinal symptoms, such as anemia, osteoporosis, neurological disorders and dermatitis herpetiformis[1][3]. Symptoms vary according to the genetic predisposition, immune status, gender and age at onset[4]. Diagnosis is made when there is the presence of the genetic factor (HLA DQ2/8), with a positive biopsy and the presence of antibody serology[5]. The typical form of the disease presents with crypt hyperplasia and villous atrophy in a malabsorptive syndrome. The atypical form of the disease is characterized by a positive serology, small changes in the mucosa of the small intestine, or no gastrointestinal symptoms associated with extra-intestinal symptoms, including osteoporosis, peripheral neuropathy, anemia and infertility[6][7]. The ophthalmic manifestations are within the extra-intestinal manifestations, and can be divided into autoimmune disorders and absorptive disabilities. The manifestations related to malnutrion are correlated to the low levels of vitamin A, vitamin D and calcium. It could cause retinopathy, cataract, dry eye and pseudotumor cerebri. The manifestations related to autoimmune disorders are orbital myositis, uveitis, thyroiditis associated with orbitopathy and brain occipital calcification.

Ophthalmologic Manifestations Related to Malnutrition

Retinopathy

Retinopathy is characterized by yellowish to white punctate lesions in the peripheral retina. Electroretinogram (ERG) changes can occur, and vitamin A levels are usually reduced in these patients[8][9]. A normal vitamin A metabolism is important for the function of the cones. The vitamin A deficiency can lead to night blindness (nyctalopia) associated with ERG changes. Nyctalopia is usually the first symptom in patients with vitamin A deficiency, which may precede the symptoms of dry eye by several months. Typically, visual function improves after one to four months of vitamin A reposition[10].

Cataract

Cataracts associated with celiac disease have been reported in the literature[11][12]. Malabsorption can be caused by chronic diarrhea. A severe vitamin D deficiency due to the malabsorptive syndrome interferes with the absorption of calcium, and the resulting hypocalcemia contributes to the development of cataracts. Chronic diarrhea can also lead to dehydration, which would alter the osmotic flow between the lens and the aqueous humor, with alkalosis and high levels of urea and ammonia. The lens maintains a good level of hydration in an environment with calcium between 10-12 mg/100 mL. Low levels of calcium in the aqueous humor change the permeability of the lens epithelium, causing an imbalance in the osmotic equilibrium and leading to lens opacification. Hypocalcemia lasting 10-12mo is sufficient to generate cataracts[13].

Pseudotumor cerebri

Pseudotumor cerebri, also known as idiopathic intracranial hypertension, may be associated with vitamin A deficiency, and is characterized by increased intracranial pressure of unknown cause[14][15]. It may be caused by nutritional, metabolic, endocrinological or hematological disorders[16][17]. The association between vitamin A and pseudotumor cerebri is more commonly reported associated with vitamin A poisoning[18]. High levels of vitamin A may damage the granulation of the arachnoid, hindering the absorption of cerebrospinal fluid[19]. However, a few case reports have described the relation between pseudotumor cerebri and low levels of vitamin A[20][22]. The clinical picture is characterized by the presence of papilledema with normal radiological images and no other cause of increased intracranial pressure[22]. The mechanism by which vitamin A deficiency results in increased intracranial pressure is still not fully understood. It was demonstrated, in animal models, that vitamin A deficiency can increase the rate of the absorption of cerebrospinal fluid, causing increased intracranial pressure[23]. Studies have confirmed this mechanism demonstrating fibrosis and increased arachnoid granules in animal vitamin A deficiency[23]. One study suggested a different mechanism of increased intracranial pressure caused by vitamin A deficiency[24]; they found a decrease in the volume of the cranial cavity and brain compression by excessive cranial bone growth in dogs with vitamin A deficiency. This increase in bone growth was noted in the bones of the posterior fossa, thus affecting the cerebellum, the pons and the medulla oblongata. Similar bone deformities were demonstrated by scientists, who found an increase in osteoblast activity in the periosteum, which led to a bone deposit in the skulls of birds with vitamin A deficiency[25]. Vitamin A deficiency can be treated with oral supplementation or, in the case of poor lipid absorption, with muscular injection. Additional doses of vitamin A may be required in patients with protein deficiency.

Dry eye

Vitamin A is necessary to maintain the proper functioning of the ocular epithelium surface. In the conjunctiva, the loss of goblet cells, and the metaplasia of the squamous cells can lead to dry eye condition in patients with vitamin A deficiency. Bitot spots due to keratinization of the perilimbal conjunctiva may be seen. In more severe cases, liquefactive necrosis of the cornea (keratomalacia) may occur[26]. Topical retinoic acid 0.1% can promote anatomical improvement of the conjunctiva and the cornea[27].

Ophthalmologic Manifestations Due to Dysimmunity

Orbital myositis

An association has been reported between celiac disease and inflammatory myopathies. High levels of anti-gliadin antibodies were found in patients with myositis[28]. Celiac disease has also been associated with neutrophil myositis[29]. An association between celiac disease and dermatomyositis has been reported in patients, and these two conditions may have a common immunological basis[30]. The pathophysiology of this disease is not yet clear, but it is usually related to eosinophil and granulomatous infiltration[31].

Patients with orbital myositis usually have diplopia, pain with eye movements and exophthalmos. It is more common in women and affects only one extra-ocular muscle[28]. This condition is well treated with corticosteroids[32][33].

Uveitis

A recent study showed an association between idiopathic uveitis and patients with celiac disease[34]. Uveitis is an inflammation of the uvea, which can lead to vision loss. Early diagnosis and prompt treatment is important to preserve vision.

Thyroiditis associated with orbitopathy

The etiology of Hashimoto's disease is unknown, but patients usually have a genetic predisposition, with the presence of HLA-DR3/DR4 or HLA-DQ2/DQ8[35][40]. The pathogenesis of Hashimoto's thyroiditis is multifactorial[41]. Endogenous hormones and external factors are suspected to trigger the manifestations of the disease[42].

Gastrointestinal immune diseases, such as celiac disease, are more prevalent in patients with Hashimoto's thyroiditis. Patients with celiac disease have four times more risk to develop Hashimoto's thyroiditis. The pathogenesis of the coexisting Hashimoto's thyroiditis and other autoimmune diseases, such as celiac disease, is still not complete understand[43][44]. The association between the orbital manifestation of the thyroiditis and celiac disease is due to a possible lymphocytic infiltration leading to tissue remodeling and fibrosis[45][46]. The local release of pro-inflammatory cytokines, tumor necrosis factors and interleukin-6 are present both in Hashimoto's thyroiditis and in celiac disease[47][48]. The presence of histocompatibility complex class II (MHC II) has been described in both thyroiditis and celiac disease[49][50].

Brain occipital calcification

The neuro-ophthalmologic manifestations result in local inflammatory alterations and vasculitis caused by immunological mechanisms. Low vision is rare in celiac disease, but has been correlated with cases of cortical calcification in the occipital region[51][52].

A study indicated that HLA, predisposing to celiac disease, is the same gene that is associated with bilateral occipital calcification[53]. The cerebral calcification may be associated with a reduction in the concentration of folate in the central nervous system, due to poor absorption of folate and transportation difficulties through the blood-brain barrier[54][56]. However, the pathophysiology of this alteration has not yet been definitely determined. Folic acid deficiency is not present in all patients with celiac disease and cerebral calcification[57]. Another hypothesis is that the brain calcification is due to an immune complex associated with endothelial inflammation[57][58]. Further studies are needed to elucidate the pathophysiology of occipital calcification.

CONCLUSION

Celiac disease has intestinal and extra-intestinal manifestations, caused by immune alterations or by nutrient malabsorption. The ophthalmic symptoms are rare within the extraintestinal manifestations, but should be investigated in patients with celiac disease and taken into consideration as the first systemic manifestations of the disease[59][60].

Acknowledgments

The authors would like to thank Brian Frederick Weymouth. for the support in the translation.

Conflicts of Interest: Martins TGS, None; Costa ALFA, None; Oyamada MK, None; Schor P, None; Sipahi AM, None.

REFERENCES

  • 1.Rampertab SD, Pooran N, Brar P, Singh P, Green PH. Trends in the presentation of celiac disease. Am J Med. 2006;119(4):355.e9–14. doi: 10.1016/j.amjmed.2005.08.044. [DOI] [PubMed] [Google Scholar]
  • 2.Ludvigsson JF, Leffler DA, Bai JC, et al. The Oslo definitions for coeliac disease and related terms. Gut. 2013;62(1):43–52. doi: 10.1136/gutjnl-2011-301346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Tursi A, Brandimarte G, Giorgetti G, Gigliobianco A, Lombardi D, Gasbarrini G. Low prevalence of antigliadin and anti-endomysium antibodies in subclinical/silent celiac disease. Am J Gastroenterol. 2001;96(5):1507–1510. doi: 10.1111/j.1572-0241.2001.03744.x. [DOI] [PubMed] [Google Scholar]
  • 4.Bai D, Brar P, Holleran S, Ramakrishnan R, Green PH. Effect of gender on the manifestations of celiac disease:evidence for greater malabsorption in men. Scand J Gastroenterol. 2005;40(2):183–187. doi: 10.1080/00365520510011498. [DOI] [PubMed] [Google Scholar]
  • 5.Adrych KJ, Marek IE, Kryszewski AJ. Adults celiac disease-the tip of the iceberg. Wiad Lek. 2006;59(5–6):359–363. [PubMed] [Google Scholar]
  • 6.Malamut G, Afchain P, Verkarre V, et al. Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II. Gastroenterology. 2009;136(1):81–90. doi: 10.1053/j.gastro.2008.09.069. [DOI] [PubMed] [Google Scholar]
  • 7.Biagi F, Corazza GR. Defining gluten refractory enteropathy. Eur J Gastroenterol Hepatol. 2001;13(5):561–565. doi: 10.1097/00042737-200105000-00016. [DOI] [PubMed] [Google Scholar]
  • 8.Alwitry A. Vitamin A deficiency in coeliac disease. Br J Ophthalmol. 2000;84(9):1079–1080. doi: 10.1136/bjo.84.9.1075e. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Chae T, Foroozan R. Vitamin A deficiency in patients with a remote history of intestinal surgery. Br J Ophthalmol. 2006;90(8):955–956. doi: 10.1136/bjo.2006.092502. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Apushkin MA, Fishman GA. Improvement in visual function and fundus findings for a patient with vitamin A-deficient retinopathy. Retina. 2005;25(5):650–652. doi: 10.1097/00006982-200507000-00016. [DOI] [PubMed] [Google Scholar]
  • 11.Maraini G, Hejtmancik JF, Shiels A, Mackay DS, Aldigeri R, Jiao XD, Williams SL, Sperduto RD, Reed G. Galactokinase gene mutations and age-related cataract. Lack of association in an Italian population. Mol Vis. 2003;9:397–400. [PubMed] [Google Scholar]
  • 12.Isaia GC, Casalis S, Grosso I, Molinatti PA, Tamone C, Sategna-Guidetti C. Hypoparathyroidism and co-existing celiac disease. J Endocrinol Invest. 2004;27(8):778–781. doi: 10.1007/BF03347523. [DOI] [PubMed] [Google Scholar]
  • 13.Wang TJ, Wu CK, Hu CC, Keller JJ, Lin HC. Increased risk of co-morbid eye disease in patients with chronic renal failure: a population-based study. Ophthalmic Epidemiol. 2012;19(3):137–143. doi: 10.3109/09286586.2012.680531. [DOI] [PubMed] [Google Scholar]
  • 14.Digre KB, Corbett JJ. Idiopathic intra cranial hypertension (pseudotumor cerebri): a reappraisal. Neurologist. 2001;7:2–67. [Google Scholar]
  • 15.Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension. Neurology. 2002;59(10):1492–1495. doi: 10.1212/01.wnl.0000029570.69134.1b. [DOI] [PubMed] [Google Scholar]
  • 16.Biousse V, Bruce BB, Newman NJ. Update on the pathophysiology and management of idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatry. 2012;83(5):488–494. doi: 10.1136/jnnp-2011-302029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Soiberman U, Stolovitch C, Balcer LJ, Regenbogen M, Constantini S, Kesler A. Idiopathic intracranial hypertension in children: visual outcome and risk of recurrence. Childs Nerv Syst. 2011;27(11):1913–1918. doi: 10.1007/s00381-011-1470-5. [DOI] [PubMed] [Google Scholar]
  • 18.Digre K, Warner J. Is vitamin A implicated in the pathophysiology of increased intracranial pressure? Neurology. 2005;64(11):1827. [PubMed] [Google Scholar]
  • 19.Warner JE, Bernstein PS, Yemelyanov A, Alder SC, Farnsworth ST, Digre KB. Vitamin A in the cerebrospinal fluid of patients with and without idiopathic intracranial hypertension. Ann Neurol. 2002;52(5):647–650. doi: 10.1002/ana.10377. [DOI] [PubMed] [Google Scholar]
  • 20.Obeid M, Price J, Sun L, Scantlebury MH, Overby P, Sidhu R, Chiriboga CA, Quittell LM. Facial palsy and idiopathic intracranial hypertension in twins with cystic fibrosis and hypovitaminosis A. Pediatr Neurol. 2011;44(2):150–152. doi: 10.1016/j.pediatrneurol.2010.10.002. [DOI] [PubMed] [Google Scholar]
  • 21.McLaren DS, Kraemer K. Control. World Rev Nutr Diet. 2012;103:148–165. doi: 10.1159/000317281. [DOI] [PubMed] [Google Scholar]
  • 22.West KP., Jr Vitamin A deficiency disorders in children and women. Food Nutr Bull. 2003;24(4 suppl):S78–90. doi: 10.1177/15648265030244S204. [DOI] [PubMed] [Google Scholar]
  • 23.Weller RO. Microscopic morphology and histology of the human meninges. Morphologie. 2005;89(284):22–34. doi: 10.1016/s1286-0115(05)83235-7. [DOI] [PubMed] [Google Scholar]
  • 24.Gorocica-Buenfil MA, Fluharty FL, Bohn T, Schwartz SJ, Loerch SC. Effect of low vitamin A diets with high-moisture or dry corn on marbling and adipose tissue fatty acid composition of beef steers. J Anim Sci. 2007;85(12):3355–3366. doi: 10.2527/jas.2007-0172. [DOI] [PubMed] [Google Scholar]
  • 25.Lee K, Skromne I. Retinoic acid regulates size, pattern and alignment of tissues at the head-trunk transition. Development. 2014;141(22):4375–4384. doi: 10.1242/dev.109603. [DOI] [PubMed] [Google Scholar]
  • 26.Hos D, Cursiefen C. Severe vitamin A deficiency in a child presenting as xerophthalmia. J Pediatr. 2014;165(4):875. doi: 10.1016/j.jpeds.2014.06.054. [DOI] [PubMed] [Google Scholar]
  • 27.Lewis CD, Traboulsi EI, Rothner AD, Jeng BH. Xerophthalmia and intracranial hypertension in an autistic child with vitamin A deficiency. J Pediatr Ophthalmol Strabismus. 2011;48 Online:e1–3. doi: 10.3928/01913913-20100318-04. [DOI] [PubMed] [Google Scholar]
  • 28.Orbach H, Amitai N, Barzilai O, Boaz M, Ram M, Zandman-Goddard G, Shoenfeld Y. Autoantibodyscreen in inflammatory myopathies high prevalence of antibodies to gliadin. Ann N Y Acad Sci. 2009;1173:174–179. doi: 10.1111/j.1749-6632.2009.04810.x. [DOI] [PubMed] [Google Scholar]
  • 29.Alawneh K, Ashley C, Carlson JA. Neutrophilic myositis as a manifestation of celiac disease: a case report. Clin Rheumatol. 2008;27(Suppl. 1):S11–13. doi: 10.1007/s10067-007-0801-0. [DOI] [PubMed] [Google Scholar]
  • 30.Song MS, Farber D, Bitton A, Jass J, Singer M, Karpati G. Dermatomyositis associated with celiac disease: response to a gluten-free diet. Can J Gastroenterol. 2006;20(6):433–435. doi: 10.1155/2006/574074. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Verma S, Kroeker KI, Fedorak RN. Adalimumab for orbital myositis in a patient with Crohn's disease who discontinued infliximab: a case report and review of the literature. BMC Gastroenterol. 2013;13:59. doi: 10.1186/1471-230X-13-59. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Gordon LK. Orbital inflammatory disease: a diagnostic and therapeutic challenge. Eye (Lond) 2006;20(10):1196–1206. doi: 10.1038/sj.eye.6702383. [DOI] [PubMed] [Google Scholar]
  • 33.Gumus K, Mirza GE, Cavanagh HD, Karakucuk S. Topical cyclosporine A as a steroid-sparing agent in steroiddependent idiopathic ocular myositis with scleritis: a case report and review of the literature. Eye Contact Lens. 2009;35(5):275–278. doi: 10.1097/ICL.0b013e3181b4d135. [DOI] [PubMed] [Google Scholar]
  • 34.Mollazadegan K, Kugelberg M, Tallstedt L, Ludvigsson JF. Increased risk of uveitis in celiac disease: a nationwide cohort study. Br J Ophthalmol. 2012;96(6):857–861. doi: 10.1136/bjophthalmol-2011-301051. [DOI] [PubMed] [Google Scholar]
  • 35.Golden SH, Robinson KA, Saldanha I, Anton B, Ladenson PW. Clinical review: Prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review. J Clin Endocrinol Metab. 2009;94(6):1853–1878. doi: 10.1210/jc.2008-2291. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Lazarus JH, Marino M. Orbit-Thyroid relationship. In: Wiersinga WM, Kahaly GJ, editors. Graves' orbitopathy: a multidisciplinary approach-questions and answers. Basel: Karger; 2010. pp. 26–32. [Google Scholar]
  • 37.Grebe SK, Kahaly GJ. Laboratory testing in hyperthyroidism. Am J Med. 2012;125(9):S2. doi: 10.1016/j.amjmed.2012.05.013. [DOI] [PubMed] [Google Scholar]
  • 38.Ponto KA, Kahaly GJ. Autoimmune thyrotoxicosis: diagnostic challenges. Am J Med. 2012;125(9):S1. doi: 10.1016/j.amjmed.2012.05.011. [DOI] [PubMed] [Google Scholar]
  • 39.Daumerie C. Epidemiology. In: Wiersinga WM, Kahaly GJ, editors. Graves' orbitopathy: a multidisciplinary approach-questions and answers. Basel: Karger; 2010. pp. 33–39. [Google Scholar]
  • 40.Dittmar M, Kahaly GJ. Immunoregulatory and susceptibility genes in thyroid and polyglandular autoimmunity. Thyroid. 2005;15(3):239–250. doi: 10.1089/thy.2005.15.239. [DOI] [PubMed] [Google Scholar]
  • 41.Huber A, Menconi F, Corathers S, Jacobson EM, Tomer Y. Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis:from epidemiology to mechanisms. Endocr Rev. 2008;29(6):697–725. doi: 10.1210/er.2008-0015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.McLachlan SM, Rapoport B. Breaking tolerance to thyroid antigens: changing concepts in thyroid autoimmunity. Endocr Rev. 2014;35(1):59–105. doi: 10.1210/er.2013-1055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Du P, Ma X, Wang C. Associations of CTLA4 gene polymorphisms with Graves' Ophthalmopathy: a meta-analysis. Int J Genomics. 2014;2014:537969. doi: 10.1155/2014/537969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Schuppan D, Hahn EG. Celiac disease and its link to type 1 diabetes mellitus. J Pediatr Endocrinol Metab. 2001;14:597–605. doi: 10.1515/jpem.2001.14.s1.597. Suppl. 1. [DOI] [PubMed] [Google Scholar]
  • 45.Boschi A, Daumerie C, Spiritus M, Beguin C, Senou M, Yuksel D, Duplicy M, Costagliola S, Ludgate M, Many MC. Quantification of cells expressing the thyrotropin receptor in extraocular muscles in thyroid associated orbitopathy. Br J Ophthalmol. 2005;89(6):724–729. doi: 10.1136/bjo.2004.050807. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Kahaly GJ, Shimony O, Gellman YN, Lytton SD, Eshkar-Sebban L, Rosenblum N, Refaeli E, Kassem S, Ilany J, Naor D. Regulatory T-cells in Graves' orbitopathy: baseline findings and immunomodulation byanti-T lymphocyte globulin. J Clin Endocrinol Metab. 2011;96(2):422–429. doi: 10.1210/jc.2010-1424. [DOI] [PubMed] [Google Scholar]
  • 47.Cianci R, Pagliari D, Landolfi R, Frosali S, Colagiovanni A, Cammarota G, Pandolfi F. New insights on the role of T cells in the pathogenesis of celiac disease. J Biol Regul Homeost Agents. 2012;26(2):171–179. [PubMed] [Google Scholar]
  • 48.Kapoor A, Patwari AK, Kumar P, Jain A, Narayan S. Serum soluble interleukin-2 receptor, interleukin-6 and tumor necrosis factor alpha as markers of celiac disease activity. Indian J Pediatr. 2013;80(2):108–113. doi: 10.1007/s12098-012-0830-9. [DOI] [PubMed] [Google Scholar]
  • 49.Badenhoop K, Dieterich W, Segni M, Hofmann S, Hüfner M, Usadel KH, Hahn EG, Schuppan D. HLA DQ2 and/or DQ8 is associated with celiac disease-specific autoantibodies to tissue transglutaminase in families with thyroid autoimmunity. Am J Gastroenterol. 2001;96(5):1648–1649. doi: 10.1111/j.1572-0241.2001.03821.x. [DOI] [PubMed] [Google Scholar]
  • 50.Yin X, Latif R, Bahn R, Davies TF. Genetic profiling in Graves' disease: further evidence for lack of a distinct genetic contribution to Graves' ophthalmopathy. Thyroid. 2012;22(7):730–736. doi: 10.1089/thy.2012.0007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Martins TG, Costa AL. Decreased visual acuity secondary to celiac disease. Einstein (Sao Paulo) 2012;10(3):389–390. doi: 10.1590/s1679-45082012000300025. [DOI] [PubMed] [Google Scholar]
  • 52.Pfaender M, D'Souza WJ, Trost N, Litewka L, Paine M, Cook M. Visual disturbances representing occipital lobe epilepsy in patients with cerebral calcifications and coeliac disease: a case series. J Neurol Neurosurg Psychiatry. 2004;75(11):1623–1625. doi: 10.1136/jnnp.2003.031229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Ong MS, Kohane IS, Cai T, Gorman MP, Mandl KD. Population-level evidence for an autoimmune etiology of epilepsy. JAMA Neurol. 2014;71(5):569–574. doi: 10.1001/jamaneurol.2014.188. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Díaz RM, González-Rabelino G, Delfino A. Epilepsy, cerebral calcifications and coeliac disease. The importance of an early diagnosis. Rev Neurol. 2005;40(7):417–420. [PubMed] [Google Scholar]
  • 55.Gumus K, Koc G, Doganay S, Gorkem SB, Dogan MS, Canpolat M, Coskun A, Bilgen M. Susceptibility-Based Differentiation of Intracranial Calcification and Hemorrhage in Pediatric Patients. J Child Neurol. 2015;30(8):1029–1036. doi: 10.1177/0883073814552439. [DOI] [PubMed] [Google Scholar]
  • 56.Calvani M, Jr, Parisi P, Guaitolini C, Parisi G, Paolone G. Latent coeliac disease in a child with epilepsy, cerebral calcifications, drug-induced systemic lupus erythematosus and intestinal folic acid malabsorption associated with impairment of folic acid transport across the blood-brain barrier. Eur J Pediatr. 2001;160(5):288–292. doi: 10.1007/s004310100728. [DOI] [PubMed] [Google Scholar]
  • 57.Labate A, Gambardella A, Messina D, et al. Silent celiac disease in patients with childhood localization-related epilepsies. Epilepsia. 2001;42(9):1153–1155. doi: 10.1046/j.1528-1157.2001.45700.x. [DOI] [PubMed] [Google Scholar]
  • 58.Johnson AM, Dale RC, Wienholt L, Hadjivassiliou M, Aeschlimann D, Lawson JA. Coeliac disease, epilepsy, and cerebral calcifications: association with TG6 autoantibodies. Dev Med Child Neurol. 2013;55(1):90–93. doi: 10.1111/j.1469-8749.2012.04369.x. [DOI] [PubMed] [Google Scholar]
  • 59.Fasano A, Berti I, Gerarduzzi T, Not T, et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med. 2003;163(3):286–292. doi: 10.1001/archinte.163.3.286. [DOI] [PubMed] [Google Scholar]
  • 60.Gujral N, Freeman HJ, Thomson AB. Celiac disease: prevalence, diagnosis, pathogenesis and treatment. World J Gastroenterol. 2012;18(42):6036–6059. doi: 10.3748/wjg.v18.i42.6036. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from International Journal of Ophthalmology are provided here courtesy of Press of International Journal of Ophthalmology

RESOURCES